Henry Schein, Inc. (NASDAQ:HSIC) Given Consensus Rating of "Hold" by Brokerages

Key Points

• The consensus recommendation for Henry Schein, Inc. (NASDAQ:HSIC) by twelve analysts is a "Hold", with eight ratings suggesting hold and four ratings recommending a buy.
• Henry Schein's recent quarterly earnings report showed an EPS of $1.10, missing the consensus estimate by $0.09, while revenue increased by 3.3% year-over-year.
• Institutional investors own 96.62% of Henry Schein's stock, indicating strong interest from hedge funds and investment firms.

Henry Schein, Inc. (NASDAQ:HSIC - Get Free Report) has earned an average rating of "Hold" from the twelve research firms that are currently covering the company, Marketbeat reports. Seven research analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average 12 month target price among brokers that have issued ratings on the stock in the last year is $76.6667.

HSIC has been the topic of a number of research reports. Leerink Partners set a $75.00 target price on shares of Henry Schein in a report on Monday, July 14th. Evercore ISI raised shares of Henry Schein from an "in-line" rating to an "outperform" rating and set a $83.00 price target for the company in a research note on Tuesday. Robert W. Baird reissued a "neutral" rating and issued a $72.00 price objective (down from $82.00) on shares of Henry Schein in a research report on Monday, July 14th. Stifel Nicolaus reiterated a "hold" rating and issued a $75.00 price objective (down previously from $80.00) on shares of Henry Schein in a research note on Friday, July 25th. Finally, Baird R W lowered shares of Henry Schein from a "strong-buy" rating to a "hold" rating in a research report on Monday, July 14th.

Henry Schein Price Performance

Shares of HSIC traded up $0.01 during trading hours on Friday, reaching $68.99. 565,008 shares of the stock traded hands, compared to its average volume of 1,760,154. The company has a current ratio of 1.41, a quick ratio of 0.78 and a debt-to-equity ratio of 0.51. Henry Schein has a 52-week low of $60.56 and a 52-week high of $82.49. The company's 50-day moving average price is $70.44 and its two-hundred day moving average price is $70.21. The company has a market cap of $8.37 billion, a P/E ratio of 22.25, a price-to-earnings-growth ratio of 2.28 and a beta of 0.81.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its quarterly earnings results on Tuesday, August 5th. The company reported $1.10 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.19 by ($0.09). Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. The company had revenue of $3.24 billion during the quarter, compared to the consensus estimate of $3.22 billion. During the same quarter in the prior year, the firm posted $1.23 earnings per share. The business's revenue was up 3.3% on a year-over-year basis. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. On average, analysts anticipate that Henry Schein will post 4.74 earnings per share for the current year.

Hedge Funds Weigh In On Henry Schein

A number of institutional investors have recently bought and sold shares of HSIC. Palestra Capital Management LLC purchased a new stake in shares of Henry Schein in the 4th quarter valued at approximately $182,988,000. Ameriprise Financial Inc. raised its stake in shares of Henry Schein by 3,275.2% in the 2nd quarter. Ameriprise Financial Inc. now owns 2,266,858 shares of the company's stock valued at $165,594,000 after acquiring an additional 2,199,695 shares during the period. Norges Bank purchased a new stake in shares of Henry Schein in the 2nd quarter valued at approximately $89,476,000. Steadfast Capital Management LP raised its stake in shares of Henry Schein by 254.2% in the 4th quarter. Steadfast Capital Management LP now owns 1,637,808 shares of the company's stock valued at $113,336,000 after acquiring an additional 1,175,408 shares during the period. Finally, M.D. Sass LLC purchased a new stake in shares of Henry Schein in the 2nd quarter valued at approximately $79,201,000. 96.62% of the stock is owned by hedge funds and other institutional investors.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.